Qureator is proud to unveil the future of drug discovery at BIO 2025. We’re bridging cutting-edge AI with patient-derived organoid technology to create “lab-in-the-loop” systems—dynamic platforms that generate real-time, human-relevant data for faster, smarter drug development. This fusion of scalable, personalized biology with intelligent automation is driving a paradigm shift toward more predictive, patient-centered discovery. As regulatory landscapes evolve, Qureator is committed to setting a new standard for translational science. Join us in Boston to witness how we’re turning scientific vision into tangible therapeutic breakthroughs. The revolution in drug discovery has begun—and it’s human at its core.
Qureator Unveils AI-Driven Lab-in-the-Loop Platform for Scalable, Personalized Drug Discovery at BIO 2025
